The results displayed that growth rates and tumor weights of xenograft tumors in the sh-NC + CSF3 group were higher than in the control group, while the knockdown of PGM2L1 abolished this trend (Fig. 7A–C). The gene discussed is CSF3; the disease is neoplasm.